Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC

NCT02768558 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Another treatment found efficacious

Conditions

Non-Small Cell Lung Cancer

Interventions

RADIATION: Radiation Therapy (RT)
DRUG: Cisplatin
DRUG: Etoposide
DRUG: Nivolumab
OTHER: Placebo

Sponsor

RTOG Foundation, Inc.

Collaborators

[object Object]